A Study to Evaluate the Safety and Efficacy of Bermekimab in Patients With Moderate to Severe Atopic Dermatitis
Clinical trial NCT04021862 · COMPLETED
Trial details
- NCT number
- NCT04021862
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-16
- Primary completion
- 2020-06-30
- Enrollment
- 87
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.